The Focus:

For developers of orally inhaled drug products, paediatric patients, especially the youngest age groups, are generally not the primary focus of development. When bringing a new drug into this field, the regulatory road is already bumpy enough and from a risk management perspective putting a new drug in a new device is not a road that many pharma companies dare to take.

As a consequence of this, the devices for the youngest age groups mostly consist of good old nebulizers or add-ons for pMDIs, especially valved holding chambers with masks and indicators.

The idea to have a symposium on this special group of users came up at the initiation of the COST Action SimInhale. What are the requirements for a suitable inhaler for young patients? How does our anatomy develop from newborn to adolescent. And what are young children’s physical and cognitive skills? Can they handle a DPI? Or a soft mist inhaler? From what age does it make sense to use a mouthpiece? There would be room for one or two full days of lectures to cover all relevant issues, but this morning session prior to DDL is a good start to align on this important topic.

 Once you have registered you can download the Joining Instructions which give you more details about the venue location, booking accommodation and other important details of the event.

SimInhale Symposium Joining Instructions – Download here